Results 231 to 240 of about 972,758 (255)

No Observable Adverse Effect Level (NoAEL)

2006
openaire   +1 more source

No Observable Adverse Effect Level (NoAEL)

2015
openaire   +1 more source

Statistical uncertainty in the no-observed-adverse-effect level*1

Fundamental and Applied Toxicology, 1989
openaire   +1 more source

Obesity and adverse breast cancer risk and outcome: Mechanistic insights and strategies for intervention

Ca-A Cancer Journal for Clinicians, 2017
Cynthia Morata-Tarifa, Manuel Picon-Ruiz, Joyce M Slingerland   +2 more
exaly  

Determining the No-Observed-Adverse-Effect Level in Continuous Response

1993
Yasuki Kikuchi, Takashi Yanagawa, Harutoshi Nishiyama   +2 more
openaire   +1 more source

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Nature Reviews Clinical Oncology, 2019
Solange Peters, Camillo Ribi, John Thompson   +2 more
exaly  

Incidence and Preventability of Adverse Drug Events Among Older Persons in the Ambulatory Setting

JAMA - Journal of the American Medical Association, 2003
David W Bates, Cynthia Cadoret, Leslie R Harrold   +2 more
exaly  

Does adjuvant ipilimumab have little adverse effect on quality of life?

Nature Reviews Clinical Oncology, 2017
Adele Green, Paul Lorigan
exaly  

Adverse event profile for immunotherapy agents compared with chemotherapy in solid organ tumors: a systematic review and meta-analysis of randomized clinical trials

Annals of Oncology, 2020
Z Klaassen, R K Nam, S S Sridhar
exaly  

Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C

Nature Reviews Gastroenterology and Hepatology, 2011
Markus Peck-Radosavljevic, Mark Sulkowski, Curtis L Cooper   +2 more
exaly